Aligos Therapeutics Inc. (ALGS)
NASDAQ · Healthcare
Aligos Therapeutics Inc. Operating Income 2020–2025
Aligos Therapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Aligos Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -26.9 M, a 39.94% increase year-over-year.
- Aligos Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -93.1 M, a 6.20% increase year-over-year.
- Aligos Therapeutics Inc. annual operating income for 2025 was -88.0 M, a 1.31% decrease from 2024.
- Aligos Therapeutics Inc. annual operating income for 2024 was -89.2 M, a 1.17% increase from 2023.
- Aligos Therapeutics Inc. annual operating income for 2023 was -88.1 M, a 9.69% decrease from 2022.
- Aligos Therapeutics Inc. annual operating income for 2022 was -97.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aligos Therapeutics Inc. Operating Income — FAQ
Aligos Therapeutics Inc. (ALGS) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Aligos Therapeutics Inc.'s operating income?
Aligos Therapeutics Inc. (ALGS) reported operating income of -$88M for fiscal 2025.
Where can I see ALGS's operating income history?
The chart and table above show Aligos Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.